# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4836402 | Binding | Inhibition of human liver mitochondrial KMO assessed as reduction in 3-HK metabolite formation using L-kynurenine as substrate preincubated for 5 mins followed by substate addition and measured after 30 mins by LC-MS/MS analysis | Homo sapiens | 17 | ALA4834453 | mitochondrion format | Scientific Literature | |
2. | ALA4836403 | ADME | Metabolic stability in human liver microsomes assessed as intrinsic clearance incubated for 30 mins in presence of NADPH measured per mg protein | Homo sapiens | 17 | ALA4834453 | microsome format | Scientific Literature | |
3. | ALA4836404 | ADME | Metabolic stability in rat liver microsomes assessed as intrinsic clearance incubated for 30 mins in presence of NADPH measured per mg protein | Rattus norvegicus | 17 | ALA4834453 | microsome format | Scientific Literature | |
4. | ALA4836405 | Physicochemical | Glutathione reactivity assessed as dansylatedGSH-compound conjugate formation in presence of human liver microsomes by fluorescence detector based HPLC analysis | 17 | ALA4834453 | microsome format | Scientific Literature | ||
5. | ALA4836414 | ADME | Plasma concentration in cynomolgus monkey at 5 mg/kg, po measured after 2 hrs of administration | Macaca fascicularis | 2 | ALA4834453 | organism-based format | Scientific Literature | |
6. | ALA4836415 | ADME | Drug uptake in cynomolgus monkey striatum at 5 mg/kg, po measured after 2 hrs of administration | Macaca fascicularis | 2 | ALA4834453 | organism-based format | Scientific Literature | |
7. | ALA4836416 | ADME | Ratio of drug level in cynomolgus monkey striatum to plasma at 5 mg/kg, po measured after 2 hrs of administration | Macaca fascicularis | 2 | ALA4834453 | organism-based format | Scientific Literature | |
8. | ALA4836417 | Functional | Neuroprotective activity in R6/2 transgenic mouse model assessed as reduction in 3-HK level in striatum at 25 to 100 mg/kg, po measured after 1 hr | Mus musculus | 1 | ALA4834453 | organism-based format | Scientific Literature | |
9. | ALA4836418 | Functional | Neuroprotective activity in R6/2 transgenic mouse model assessed as increase in KYNA level in striatum at 25 to 100 mg/kg, po measured after 1 hr relative to control | Mus musculus | 1 | ALA4834453 | organism-based format | Scientific Literature | |
10. | ALA4836419 | Functional | Neuroprotective activity in R6/2 transgenic mouse model assessed as reduction in 3-HK level in striatum at 100 mg/kg, po measured after 24 hrs | Mus musculus | 1 | ALA4834453 | organism-based format | Scientific Literature | |
11. | ALA4836423 | ADME | Clearance in cynomolgus monkey at 0.482 mg/kg, iv | Macaca fascicularis | 1 | ALA4834453 | organism-based format | Scientific Literature | |
12. | ALA4836424 | ADME | Half life in cynomolgus monkey plasma at 0.482 mg/kg, iv | Macaca fascicularis | 1 | ALA4834453 | organism-based format | Scientific Literature | |
13. | ALA4836425 | ADME | Oral bioavailability in cynomolgus monkey at 5 mg/kg | Macaca fascicularis | 1 | ALA4834453 | organism-based format | Scientific Literature | |
14. | ALA4836426 | ADME | Protein binding in cynomolgus monkey striatum at 5 mg/kg, po measured after 2 hrs | Macaca fascicularis | 1 | ALA4834453 | organism-based format | Scientific Literature |